Show simple item record

dc.contributor.authorZhao, Y
dc.contributor.authorFu, X
dc.contributor.authorLopez, JI
dc.contributor.authorRowan, A
dc.contributor.authorAu, L
dc.contributor.authorFendler, A
dc.contributor.authorHazell, S
dc.contributor.authorXu, H
dc.contributor.authorHorswell, S
dc.contributor.authorShepherd, STC
dc.contributor.authorSpain, L
dc.contributor.authorByrne, F
dc.contributor.authorStamp, G
dc.contributor.authorO'Brien, T
dc.contributor.authorNicol, D
dc.contributor.authorAugustine, M
dc.contributor.authorChandra, A
dc.contributor.authorRudman, S
dc.contributor.authorToncheva, A
dc.contributor.authorPickering, L
dc.contributor.authorSahai, E
dc.contributor.authorLarkin, J
dc.contributor.authorBates, PA
dc.contributor.authorSwanton, C
dc.contributor.authorTurajlic, S
dc.contributor.authorTRACERx Renal Consortium,
dc.contributor.authorLitchfield, K
dc.coverage.spatialEngland
dc.date.accessioned2022-08-17T13:50:32Z
dc.date.available2022-08-17T13:50:32Z
dc.date.issued2021-05-17
dc.identifier10.1038/s41559-021-01456-6
dc.identifier.citationNature Ecology and Evolution, 2021, 5 (7), pp. 1033 - 1045
dc.identifier.issn2397-334X
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5276
dc.identifier.eissn2397-334X
dc.identifier.eissn2397-334X
dc.identifier.doi10.1038/s41559-021-01456-6
dc.description.abstractThe genetic evolutionary features of solid tumour growth are becoming increasingly well described, but the spatial and physical nature of subclonal growth remains unclear. Here, we utilize 102 macroscopic whole-tumour images from clear cell renal cell carcinoma patients, with matched genetic and phenotypic data from 756 biopsies. Utilizing a digital image processing pipeline, a renal pathologist marked the boundaries between tumour and normal tissue and extracted positions of boundary line and biopsy regions to X and Y coordinates. We then integrated coordinates with genomic data to map exact spatial subclone locations, revealing how genetically distinct subclones grow and evolve spatially. We observed a phenotype of advanced and more aggressive subclonal growth in the tumour centre, characterized by an elevated burden of somatic copy number alterations and higher necrosis, proliferation rate and Fuhrman grade. Moreover, we found that metastasizing subclones preferentially originate from the tumour centre. Collectively, these observations suggest a model of accelerated evolution in the tumour interior, with harsh hypoxic environmental conditions leading to a greater opportunity for driver somatic copy number alterations to arise and expand due to selective advantage. Tumour subclone growth is predominantly spatially contiguous in nature. We found only two cases of subclone dispersal, one of which was associated with metastasis. The largest subclones spatially were dominated by driver somatic copy number alterations, suggesting that a large selective advantage can be conferred to subclones upon acquisition of these alterations. In conclusion, spatial dynamics is strongly associated with genomic alterations and plays an important role in tumour evolution.
dc.formatPrint-Electronic
dc.format.extent1033 - 1045
dc.languageeng
dc.language.isoeng
dc.publisherNATURE PORTFOLIO
dc.relation.ispartofNature Ecology and Evolution
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserved
dc.subjectDNA Copy Number Variations
dc.subjectEvolution, Molecular
dc.subjectGenomics
dc.subjectHumans
dc.subjectMutation
dc.subjectNeoplasms
dc.titleSelection of metastasis competent subclones in the tumour interior.
dc.typeJournal Article
dcterms.dateAccepted2021-03-03
dc.date.updated2022-08-17T13:49:42Z
rioxxterms.versionAM
rioxxterms.versionofrecord10.1038/s41559-021-01456-6
rioxxterms.licenseref.startdate2021-05-17
rioxxterms.typeJournal Article/Review
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/34002049
pubs.issue7
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Experimental Pathology
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Melanoma and Kidney Cancer/Melanoma and Kidney Cancer (hon.)
pubs.organisational-group/ICR/Students
pubs.organisational-group/ICR/Students/PhD and MPhil
pubs.organisational-group/ICR/Students/PhD and MPhil/17/18 Starting Cohort
pubs.organisational-group/ICR/Students/PhD and MPhil/18/19 Starting Cohort
pubs.organisational-group/ICR/ImmNet
pubs.publication-statusPublished
pubs.volume5
icr.researchteamMelanoma & Kidney Cancer
icr.researchteamExperimental Pathology
dc.contributor.icrauthorAu, Lewis
dc.contributor.icrauthorShepherd, Scott
icr.provenanceDeposited by Mr Arek Surman (impersonating Prof James Larkin) on 2022-08-17. Deposit type is initial. No. of files: 1. Files: EMS135040.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record